Scilex Holding (SCLX) Non-Current Debt (2021 - 2025)

Scilex Holding (SCLX) posted quarterly Non-Current Debt of $22.5 million for Q4 2025, up 2560.36% year-over-year from $845000.0 in Q4 2024, and up 2560.36% on a QoQ basis from $845000.0 in Q4 2024.

Scilex Holding (SCLX) Non-Current Debt (2021 - 2025) Analysis & Trends

Scilex Holding (SCLX) has reported Non-Current Debt for 5 consecutive years, with $22.5 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Non-Current Debt rose 2560.36% year-over-year to $22.5 million; the TTM figure through Dec 2025 stood at $22.5 million (up 2560.36% YoY), while the FY2025 annual figure was $22.5 million, up 2560.36% from the prior year.
  • Non-Current Debt came in at $22.5 million for Q4 2025 at Scilex Holding, up from $845000.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $72.0 million in Q4 2021, with the low at $845000.0 in Q4 2024.
  • Average Non-Current Debt over 5 years is $18.4 million, with a median of $15.3 million recorded in 2024.
  • Across the five-year window, Non-Current Debt plunged 95.04% in 2024 and jumped 2560.36% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $72.0 million in 2021, then plunged by 95.87% to $3.0 million in 2022, then surged by 473.35% to $17.0 million in 2023, then slumped by 95.04% to $845000.0 in 2024, then surged by 2560.36% to $22.5 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $22.5 million, $845000.0, and $14.3 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 39.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 37.53 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 64.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -24.45 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 46.67 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 20.86 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 60.57 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 22.48 Mn
Dec 31, 2024 845,000.00
Sep 30, 2024 14.33 Mn
Jun 30, 2024 29.03 Mn
Mar 31, 2024 16.32 Mn
Dec 31, 2023 17.04 Mn
Sep 30, 2023 6.93 Mn
Sep 30, 2022 2.97 Mn
Jun 30, 2022 2.00 Mn
Dec 31, 2021 72.04 Mn